| mRNA |
Repligen 136 |
CTRPv2 |
pan-cancer |
AAC |
0.071 |
0.05 |
| mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.068 |
0.05 |
| mRNA |
tigecycline |
CTRPv2 |
pan-cancer |
AAC |
-0.092 |
0.05 |
| mRNA |
GDC-0879 |
CTRPv2 |
pan-cancer |
AAC |
0.067 |
0.05 |
| mRNA |
Nilotinib |
CCLE |
pan-cancer |
AAC |
-0.095 |
0.05 |
| mRNA |
Cytarabine |
FIMM |
pan-cancer |
AAC |
-0.31 |
0.05 |
| mRNA |
SB 505124 |
GDSC1000 |
pan-cancer |
AAC |
-0.073 |
0.05 |
| mRNA |
Mdivi-1 |
CTRPv2 |
pan-cancer |
AAC |
0.068 |
0.06 |
| mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.07 |
0.06 |
| mRNA |
MLN4924 |
CTRPv2 |
pan-cancer |
AAC |
0.063 |
0.06 |